NVDA
NVIDIA Corporation
NVDA has the edge over TSEM overall, supported by stronger valuation and stronger fundamentals.
TSEM
Tower Semiconductor Ltd.
TSEM's outlook is improving despite an expensive valuation.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
TSEM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
TSEM's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over TSEM in the historical PE scenario, which offers more potential upside but is not a forecast.
TSEM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $27.61 | -83% |
| Forward | 25x | $158 | — |
| Fair | 26x | $66.20 | -58% |
| Expensive | 42x | $106 | -33% |
| Current | 62x | $158 | — |
Historical ranges are pointers, not guarantees.
TSEM's PE is in its expensive range at 62x. If earnings grow as analysts expect, today's price would be 25x next year's earnings, in its fair range.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
TSEM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
TSEM has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over TSEM on earnings, with more consistent year-over-year improvement.
TSEM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.34 | +151% |
| Q2 2026 | $2.53 | +45% |
| Q1 2026 | $2.15 | +19% |
| Q4 2025 | $1.93 | +3.8% |
| Q3 2025 | $1.72 | -7% |
| Q2 2025 | $1.74 | -61% |
| Q1 2025 | $1.81 | -59% |
| Q4 2024 | $1.86 | -60% |
| Q3 2024 | $1.85 | -62% |
TSEM's earnings per share have fallen from their peak: $2.53 over the past year, against $4.92 in late 2023.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over TSEM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over TSEM on profitability, with a higher operating margin.
TSEM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $460.1M | +24% |
| Q1 2026 | $413.6M | +15% |
| Q4 2025 | $440.2M | +14% |
| Q3 2025 | $395.7M | +6.8% |
| Q2 2025 | $372.1M | +5.9% |
| Q1 2025 | $358.2M | +9.5% |
| Q4 2024 | $387.2M | +10% |
| Q3 2024 | $370.5M | +3.4% |
TSEM's revenue has grown year over year for eight quarters in a row: $460M last quarter, up 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 20% | +8.9 points |
| Q1 2026 | 16% | +6.4 points |
| Q4 2025 | 16% | +4.1 points |
| Q3 2025 | 13% | -2.3 points |
| Q2 2025 | 11% | -5 points |
| Q1 2025 | 9.2% | -1.2 points |
| Q4 2024 | 12% | -0.8 points |
| Q3 2024 | 15% | -86 points |
TSEM's operating margin was 20% last quarter, up 8.9 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over TSEM on cash flow, with more consistent year-over-year improvement.
TSEM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$9.6M | -181% |
| Q1 2026 | $353.6M | +$371.1M |
| Q4 2025 | -$75.3M | -2680% |
| Q3 2025 | $35.9M | +$38.8M |
| Q2 2025 | $11.9M | +2436% |
| Q1 2025 | -$17.5M | -245% |
| Q4 2024 | $2.9M | +$25.6M |
| Q3 2024 | -$2.9M | -101% |
TSEM's free cash flow has turned positive again: $305M over the past year, against −$6M the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over TSEM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
TSEM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +85K shares |
| 1 year | +1% | +1.1M shares |
| 3 years | +2.9% | +3.2M shares |
| 5 years | +4.4% | +4.8M shares |
| Available history | +6.3% | +6.8M shares |
TSEM has 114M diluted shares, up 1% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
TSEM hasn't bought back shares in the past year.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
TSEM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | -0.2x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
| Q3 2024 | -0.1x | Net Cash |
TSEM has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
TSEM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.7 | Neutral |
| Stochastic | 9.7 | Oversold |
TSEM's weekly RSI is 41 (neutral) and its Stochastic is 10 (oversold).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over TSEM on valuation relative to its sector.
TSEM PE vs Technology Sector
| Metric | TSEM | Sector median | Relative |
|---|---|---|---|
| PE | 62x | 28x | 124% above |
| PE % | 87 | 35 | 52 pts above |
TSEM is trading at 62x earnings, a 124% premium to the Technology sector's median of 28x.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
TSEM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $190.6 | 17% below |
| 20 week MA | $213.0 | 26% below |
| 50 week MA | $191.3 | 17% below |
| 100 week MA | $122.3 | 29% above |
| 200 week MA | $79.4 | 99% above |
TSEM has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
TSEM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.3 | $25.4 | +4.7% |
| 2021 | $25.4 | $38.4 | +51% |
| 2022 | $38.4 | $43.9 | +14% |
| 2023 | $43.9 | $30.5 | -31% |
| 2024 | $30.5 | $52.1 | +71% |
| 2025 | $52.1 | $121.6 | +134% |
| 2026 YTD | $121.6 | $157.9 | +30% |
TSEM has the edge over NVDA on returns for 2026, with the stronger performance.